My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 510

    1.

    Oncolytic vaccinia therapy of squamous cell carcinoma.

    Yu Z, Li S, Brader P, Chen N, Yu YA, Zhang Q, Szalay AA, Fong Y, Wong RJ.

    Mol Cancer. 2009 Jul 6;8:45.PMID: 19580655 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.

    Kelly KJ, Woo Y, Brader P, Yu Z, Riedl C, Lin SF, Chen N, Yu YA, Rusch VW, Szalay AA, Fong Y.

    Hum Gene Ther. 2008 Aug;19(8):774-82.PMID: 18754710 [PubMed - indexed for MEDLINE]Related articles

    3.

    Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

    Zhang Q, Yu YA, Wang E, Chen N, Danner RL, Munson PJ, Marincola FM, Szalay AA.

    Cancer Res. 2007 Oct 15;67(20):10038-46.PMID: 17942938 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.

    Lin SF, Yu Z, Riedl C, Woo Y, Zhang Q, Yu YA, Timiryasova T, Chen N, Shah JP, Szalay AA, Fong Y, Wong RJ.

    Surgery. 2007 Dec;142(6):976-83; discussion 976-83. Epub 2007 Nov 5.PMID: 18063085 [PubMed - indexed for MEDLINE]Related articles

    5.

    Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.

    Yu YA, Galanis C, Woo Y, Chen N, Zhang Q, Fong Y, Szalay AA.

    Mol Cancer Ther. 2009 Jan;8(1):141-51.PMID: 19139123 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.

    Lin SF, Price DL, Chen CH, Brader P, Li S, Gonzalez L, Zhang Q, Yu YA, Chen N, Szalay AA, Fong Y, Wong RJ.

    J Clin Endocrinol Metab. 2008 Nov;93(11):4403-7. Epub 2008 Aug 12.PMID: 18697871 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.

    Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y.

    J Am Coll Surg. 2001 Jul;193(1):12-21.PMID: 11442249 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.

    Sung CK, Choi B, Wanna G, Genden EM, Woo SL, Shin EJ.

    Laryngoscope. 2008 Feb;118(2):237-42.PMID: 18043494 [PubMed - indexed for MEDLINE]Related articles

    9.

    Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.

    Shin EJ, Wanna GB, Choi B, Aguila D 3rd, Ebert O, Genden EM, Woo SL.

    Laryngoscope. 2007 Feb;117(2):210-4.PMID: 17204993 [PubMed - indexed for MEDLINE]Related articles

    10.

    Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.

    Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA.

    Cancer Gene Ther. 2009 Apr;16(4):320-8. Epub 2008 Oct 24.PMID: 18949014 [PubMed - indexed for MEDLINE]Related articles

    11.

    Engineered measles virus as a novel oncolytic therapy against prostate cancer.

    Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E.

    Prostate. 2009 Jan 1;69(1):82-91.PMID: 18973133 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.

    Chen N, Zhang Q, Yu YA, Stritzker J, Brader P, Schirbel A, Samnick S, Serganova I, Blasberg R, Fong Y, Szalay AA.

    Mol Med. 2009 May-Jun;15(5-6):144-51. Epub 2009 Feb 25.PMID: 19287510 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy.

    Frentzen A, Yu YA, Chen N, Zhang Q, Weibel S, Raab V, Szalay AA.

    Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12915-20. Epub 2009 Jul 15.PMID: 19617539 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinoma.

    Price DL, Lin SF, Han Z, Simpson G, Coffin RS, Wong J, Li S, Fong Y, Wong RJ.

    Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):151-8.PMID: 20157061 [PubMed - indexed for MEDLINE]Related articles

    15.

    Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.

    Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P, Burnazi EM, Ghani RE, Serganova I, Hricak H, Szalay AA, Fong Y, Blasberg RG.

    Clin Cancer Res. 2009 Jun 1;15(11):3791-801. Epub 2009 May 26.PMID: 19470726 [PubMed - indexed for MEDLINE]Related articles

    16.

    Telomerase-specific virotheranostics for human head and neck cancer.

    Kurihara Y, Watanabe Y, Onimatsu H, Kojima T, Shirota T, Hatori M, Liu D, Kyo S, Mizuguchi H, Urata Y, Shintani S, Fujiwara T.

    Clin Cancer Res. 2009 Apr 1;15(7):2335-43. Epub 2009 Mar 24.PMID: 19318473 [PubMed - indexed for MEDLINE]Related articles

    17.

    Telomerase-specific virotherapy in an animal model of human head and neck cancer.

    Nakajima O, Matsunaga A, Ichimaru D, Urata Y, Fujiwara T, Kawakami K.

    Mol Cancer Ther. 2009 Jan;8(1):171-7.PMID: 19139126 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.

    Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.

    Cancer Gene Ther. 2006 Mar;13(3):326-34.PMID: 16138120 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.

    Worschech A, Chen N, Yu YA, Zhang Q, Pos Z, Weibel S, Raab V, Sabatino M, Monaco A, Liu H, Monsurró V, Buller RM, Stroncek DF, Wang E, Szalay AA, Marincola FM.

    BMC Genomics. 2009 Jul 7;10:301.PMID: 19583830 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.

    Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE.

    Cancer Res. 2006 Jul 15;66(14):7185-94.PMID: 16849565 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk